These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26457576)

  • 61. Relapsing pure red cell aplasia associated with B-cell chronic lymphocytic leukemia successfully treated by intravenous immunoglobulin concentrate.
    Castelli R; Vismara A; Pavia G; Dagani R; Porro T
    Ann Ital Med Int; 2002; 17(1):47-50. PubMed ID: 11975114
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Risk factors and long-term outcomes of parvovirus B19 infection in kidney transplant patients.
    Baek CH; Kim H; Yang WS; Han DJ; Park SK
    Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28741797
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Parvovirus B19 infection in a hypogammaglobulinemic infant with neurologic disorders and anemia: successful immunoglobulin therapy.
    Nigro G; D'Eufemia P; Zerbini M; Krzysztofiak A; Finocchiaro R; Giardini O
    Pediatr Infect Dis J; 1994 Nov; 13(11):1019-21. PubMed ID: 7845728
    [No Abstract]   [Full Text] [Related]  

  • 64. Pure red cell aplasia and HIV infection: what to suspect?
    Vaz SO; Guerra IC; Freitas MI; Marques L
    BMJ Case Rep; 2018 Apr; 2018():. PubMed ID: 29680800
    [No Abstract]   [Full Text] [Related]  

  • 65. Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
    Helbig G; Stella-Holowiecka B; Krawczyk-Kulis M; Wojnar J; Markiewicz M; Wojciechowska-Sadus M; Kopera M; Kruzel T; Najda J; Nowak K; Holowiecki J
    Haematologica; 2005 Nov; 90 Suppl():ECR33. PubMed ID: 16266924
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Treatment of erythropoietin-induced pure red cell aplasia: a retrospective study.
    Verhelst D; Rossert J; Casadevall N; Krüger A; Eckardt KU; Macdougall IC
    Lancet; 2004 May; 363(9423):1768-71. PubMed ID: 15172775
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Recurrent granulocytic aplasia as clinical presentation of a persistent parvovirus B19 infection.
    Pont J; Puchhammer-Stöckl E; Chott A; Popow-Kraupp T; Kienzer H; Postner G; Honetz N
    Br J Haematol; 1992 Feb; 80(2):160-5. PubMed ID: 1550770
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Parvovirus B19 (B19) and cytomegalovirus (CMV) infections and anti-erythropoietin (anti-EPO) antibodies in patients on dialysis hyporesponsive to erythropoietin therapy.
    Alves MT; Vilaça SS; Godoi LC; Rezende Júnior L; Carvalho Md; Silva Fde S; Guimarães FL; Fernandes AP; Dusse LM; Gomes KB
    Clin Chim Acta; 2014 Apr; 431():52-7. PubMed ID: 24513539
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Postpartum parvovirus B19-associated acute pure red cell aplasia and hemophagocytic syndrome].
    Tsuda H; Shirono K; Shimizu K; Shimomura T
    Rinsho Ketsueki; 1995 Jul; 36(7):672-6. PubMed ID: 7563595
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Parvovirus B19 infection after kidney transplantation].
    Brodin-Sartorius A; Mekki Y; Bloquel B; Rabant M; Legendre C
    Nephrol Ther; 2012 Feb; 8(1):5-12. PubMed ID: 21757415
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Human parvovirus B19-induced aplastic crisis in a patient treated with fibrin sealant].
    Hino M; Yamamura R; Nishiki S; Ohta K; Yamane T; Takubo T; Tatsumi N
    Rinsho Ketsueki; 1999 Feb; 40(2):145-9. PubMed ID: 10199210
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Parvovirus B19 infections.
    Sabella C; Goldfarb J
    Am Fam Physician; 1999 Oct; 60(5):1455-60. PubMed ID: 10524489
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Erythema infectiosum and other parvovirus B19 infections.
    Kirchner JT
    Am Fam Physician; 1994 Aug; 50(2):335-41. PubMed ID: 8042568
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Progress of research on human parvovirus B19 infection after renal transplantation.
    Ma Y; Man J; Niu J; Yang L
    Transplant Rev (Orlando); 2022 Dec; 36(4):100730. PubMed ID: 36368223
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Transient aplasia of the red progenitor cells manifest in a child with double heterozygote Hb SC carriership: the role of human parvovirus B19 (HPV-B19)].
    De Caluwé JP; Gilbert L; Alexander M
    Rev Med Brux; 1993 May; 14(5):141-4. PubMed ID: 8321934
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Transient erythroblastopenia in 4 children].
    Carrette M; Brock P; Uyttebroeck A; Van Geet C; Segers K; Casteels-Van Daele M
    Ned Tijdschr Geneeskd; 1995 Nov; 139(46):2375-7. PubMed ID: 7501078
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients.
    Ki CS; Kim IS; Kim JW; Lee NY; Kim SH; Lee KW; Kim SJ; Joh JW; Huh WS; Oh HY
    Clin Transplant; 2005 Dec; 19(6):751-5. PubMed ID: 16313320
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Parvovirus B19 in human disease.
    Brown KE; Young NS
    Annu Rev Med; 1997; 48():59-67. PubMed ID: 9046945
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Recurrent anemia in kidney transplant recipients with parvovirus B19 infection.
    Renoult E; Bachelet C; Krier-Coudert MJ; Diarrassouba A; André JL; Kessler M
    Transplant Proc; 2006 Sep; 38(7):2321-3. PubMed ID: 16980079
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Parvovirus B19 infection in pediatric transplant patients.
    Nour B; Green M; Michaels M; Reyes J; Tzakis A; Gartner JC; McLoughlin L; Starzl TE
    Transplantation; 1993 Oct; 56(4):835-8. PubMed ID: 8212203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.